Basic Information
Basic information for SNHG14-317-31aa
Peptide Name SNHG14-317-31aa
Genome Position chr15:25228829-25228911,25229294-25229303[+]
Species Human
Peptide Sequence MSVSQVLSLWCAETLTLPGTLVSCTELGFST
Peptide Length 31
Unique No (SNHG14-203-31aa,SNHG14-207-31aa,SNHG14-225-31aa,SNHG14-228-31aa,SNHG14-229-31aa,SNHG14-244-31aa,SNHG14-273-31aa-1,SNHG14-285-31aa,SNHG14-294-31aa,SNHG14-295-31aa,SNHG14-326-31aa,SNHG14-327-31aa,SNHG14-329-31aa,SNHG14-331-31aa)
Grand Average of Hydropathicity 0.8258
Relative Molecular Mass 3815.43
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000668570;SNHG14-317
Transcript Length 4660
Coding Ability 0.4803
DNA Sequence Corresponding to Peptide ATGTCTGTCAGCCAGGTGCTCAGCCTCTGGTGCGCTGAAACTCTGACCCTTCCTGGCACACTGGTCTCCTGCACTGAGCTGGGATTTTCCACC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :